Psyched Wellness Announces Commencement of Next Pre-Clinical Study on AME-1 Post published:October 7, 2021 Post category:Press Release
Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1 Post published:September 21, 2021 Post category:Press Release
Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on AME-1 Post published:September 8, 2021 Post category:Press Release
Psyched Wellness Submits Applications for Four Further Provisional Patents Surrounding Its Work on the AME-1 Post published:August 17, 2021 Post category:Press Release
Psyched Wellness Enters into a Service Agreement with CannaLabs to Begin Stability Tests on AME-1 Post published:July 26, 2021 Post category:Press Release
Psyched Wellness Receives Positive Results from Its 14-Day Oral Toxicity Preclinical Study Post published:July 6, 2021 Post category:Press Release
Psyched Wellness Announces Matthew Singh Joins Team as CPG and Branding Consultant Post published:June 30, 2021 Post category:Press Release
Psyched Wellness Signs Supply Agreement for Amanita Muscaria Post published:May 4, 2021 Post category:Press Release
Psyched Wellness Initiates the Next Pre-Clinical Trial Study on AME-1 Post published:April 27, 2021 Post category:Press Release